Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald E Tsai

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Onkologie|December 9, 2008
Rituximab for PTLD of the CNS: is it a 'no-brainer'?Ran Reshef, Donald E Tsai
Medical Oncology (Northwood, London, England)|September 13, 2007
The management of posttransplant lymphoproliferative disorderNoelle V Frey, Donald E Tsai
Clinics in Chest Medicine|November 3, 2005
Post-transplant lymphoproliferative disorderAlison W Loren, Donald E Tsai
Current Opinion in Hematology|May 18, 2010
Treatment advances in posttransplant lymphoproliferative diseaseCourtney D DiNardo, Donald E Tsai
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2006
Management of patients with post-transplant lymphoproliferative disorder: the role of rituximabJakub Svoboda, Robert Kotloff, Donald E Tsai
Clinics in Chest Medicine|November 13, 2017
Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell TransplantationSarah J Nagle, Ran Reshef, Donald E Tsai
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 8, 2009
Posttransplant lymphoproliferative disorder following kidney transplantAlicia K Morgans, Ran Reshef, Donald E Tsai
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2003
Use of serum protein electrophoresis to monitor patients with post-transplant lymphoproliferative disorderNicole A Aqui, John E Tomaszewski, David Goodman, et al.
American Journal of Hematology|August 29, 2007
Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin levelDonald E Tsai, Anthony Mato, David L Porter, et al.
The Annals of Pharmacotherapy|October 18, 2007
Posttransplant lymphoproliferative disorderMatthew J Everly, Roy D Bloom, Donald E Tsai, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Onkologie|December 9, 2008
Rituximab for PTLD of the CNS: is it a 'no-brainer'?Ran Reshef, Donald E Tsai
Medical Oncology (Northwood, London, England)|September 13, 2007
The management of posttransplant lymphoproliferative disorderNoelle V Frey, Donald E Tsai
Clinics in Chest Medicine|November 3, 2005
Post-transplant lymphoproliferative disorderAlison W Loren, Donald E Tsai
Current Opinion in Hematology|May 18, 2010
Treatment advances in posttransplant lymphoproliferative diseaseCourtney D DiNardo, Donald E Tsai
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2006
Management of patients with post-transplant lymphoproliferative disorder: the role of rituximabJakub Svoboda, Robert Kotloff, Donald E Tsai
Clinics in Chest Medicine|November 13, 2017
Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell TransplantationSarah J Nagle, Ran Reshef, Donald E Tsai
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 8, 2009
Posttransplant lymphoproliferative disorder following kidney transplantAlicia K Morgans, Ran Reshef, Donald E Tsai
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2003
Use of serum protein electrophoresis to monitor patients with post-transplant lymphoproliferative disorderNicole A Aqui, John E Tomaszewski, David Goodman, et al.
American Journal of Hematology|August 29, 2007
Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin levelDonald E Tsai, Anthony Mato, David L Porter, et al.
The Annals of Pharmacotherapy|October 18, 2007
Posttransplant lymphoproliferative disorderMatthew J Everly, Roy D Bloom, Donald E Tsai, et al.
Pageof 7